Home
About us
Corporate Profile
Awards and Qualification
Social Responsibility
Diseases and solutions
Cardiovascular diseases
Uncontrolled and Resistant Hypertension
Peripheral Artery Disease
Vascular calcification (VC)
Product Center
Bioresorbable Scaffolds (BRS) and Ancillary Products
Renal Denervation (RDN)
Investor Relations
Corporate Information
Corporate Governance
Financial Reports
Performance Report
Prospectus
Announcements and Circulars
Investor Enquiries
News Center
News
Video
Contact us
Contact Us/Recruitment
简 / 繁 / EN
简体中文
繁體中文
English
Announcements and circulars
Keep up to date with our news
Select year
...
All categories
...
2024-06-21
ARTICLES OF ASSOCIATION
2024-06-21
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2024-06-21
POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING HELD ON JUNE 21, 2024; RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS; APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS; CHANGE OF COMPOSITION OF BOARD COMMITTEES; AND AMENDMENTS TO THE ARTICLES OF ASS
2024-06-06
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2024
2024-05-29
PROXY FORM FOR USE AT THE 2023 ANNUAL GENERAL MEETING
2024-05-29
WORK REPORT OF THE BOARD OF DIRECTORS FOR 2023 WORK REPORT OF THE SUPERVISORY COMMITTEE FOR 2023 PROFIT DISTRIBUTION PLAN FOR 2023 AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR 2023 2023 ANNUAL REPORT RE-APPOINTMENT OF AUDITORS FOR 2024 PROPOSED APPOINTME
2024-05-29
NOTICE OF 2023 ANNUAL GENERAL MEETING
2024-05-22
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS; PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTORS; AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2024-05-07
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2024
2024-04-26
2023 ANNUAL REPORT
2024-04-05
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2024
2024-03-25
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023
2024-03-13
DATE OF BOARD MEETING
2024-03-05
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 29 February 2024
2024-02-08
CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
2024-02-05
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2024
2024-01-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2023
2023-12-05
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2023
2023-11-01
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2023
2023-10-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2023
2023-09-21
2023 INTERIM REPORT
2023-09-04
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2023
2023-08-31
CHANGE OF EMPLOYEE REPRESENTATIVE SUPERVISOR
2023-08-11
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
2023-08-04
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2023
2023-08-01
DATE OF BOARD MEETING
2023-07-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2023
2023-06-26
ARTICLES OF ASSOCIATION
2023-06-26
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2023-06-26
POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING HELD ON JUNE 26, 2023; RETIREMENT OF DIRECTORS; APPOINTMENT OF MEMBERS FOR THE SECOND SESSION OF THE BOARD AND THE SUPERVISORY COMMITTEE; APPOINTMENT OF CHAIRMAN FOR THE SECOND SESSION OF THE BOARD AND THE S
2023-06-05
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2023
2023-05-30
REPLY SLIP FOR THE 2022 ANNUAL GENERAL MEETING
2023-05-30
PROXY FORM FOR USE AT THE 2022 ANNUAL GENERAL MEETING
2023-05-30
NOTICE OF 2022 ANNUAL GENERAL MEETING
2023-05-30
2022 WORK REPORT OF THE BOARD & THE SUPERVISORY COMMITTEE 2022 PROFIT DISTRIBUTION PLAN 2022 FINANCIAL STATEMENTS 2022 ANNUAL REPORT RE-APPOINTMENT OF AUDITORS FOR 2023 ELECTION OF DIRECTORS & SUPERVISORS OF THE SECOND SESSION OF THE BOARD AND THE SUPERVI
2023-05-19
RETIREMENT OF NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTOR AT THE AGM PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2023-05-04
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2023
2023-04-26
2022 ANNUAL REPORT
2023-04-14
CONNECTED TRANSACTION CAPITAL INCREASE IN SHANGHAI XINZHI MEDICAL TECHNOLOGY CO., LTD.
2023-04-11
VOLUNTARY ANNOUNCEMENT ACHIEVEMENT OF PRIMARY CLINICAL ENDPOINT IN THE IBERIS-HTN
2023-04-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2023
2023-03-31
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE
2023-03-31
RETIREMENT OF NON-EXECUTIVE DIRECTOR AT THE AGM AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2023-03-31
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022 AND CHANGE OF USE OF PROCEEDS FROM THE GLOBAL OFFERING
2023-03-27
VOLUNTARY ANNOUNCEMENT BIO-HEART ANNOUNCES FIRST PATIENT ENROLLMENT IN THE RADIUS-HTN TRIAL
2023-03-20
DATE OF BOARD MEETING
2023-03-03
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 28 February 2023
2023-02-06
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2023
2023-01-16
Next Day Disclosure Return
2023-01-13
ANNOUNCEMENT REGARDING COMPLETION OF "FULL CIRCULATION" OF DOMESTIC SHARES AND CERTAIN UNLISTED FOREIGN SHARES OF THE COMPANY
2023-01-05
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2022
2023-01-04
ANNOUNCEMENT REGARDING "FULL CIRCULATION" OF DOMESTIC SHARES AND CERTAIN UNLISTED FOREIGN SHARES OF THE COMPANY LISTING APPROVAL GRANTED BY THE STOCK EXCHANGE
2022-12-06
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2022
2022-11-18
VOLUNTARY ANNOUNCEMENT Iberis multi-electrode RDN system (RDN) is expected to be approved in Hainan pilot zone for urgent clinical use
2022-11-18
VOLUNTARY ANNOUNCEMENT A CLINICAL TRIAL OF SIROLIMUS DRUG-ELUTING BALLOON FOR THE TREATMENT OF IN-STENT RESTENOSIS WILL BE CONDUCTED IN JAPAN
2022-11-10
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2022-11-10
POLL RESULTS OF THE 2022 FIRST EXTRAORDINARY GENERAL MEETING HELD ON NOVEMBER 10, 2022; CHANGE OF DIRECTOR; CHANGE OF COMPOSITION OF REMUNERATION COMMITTEE AND CHANGE OF SUPERVISOR
2022-11-06
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2022
2022-10-25
NOTICE OF 2022 FIRST EXTRAORDINARY GENERAL MEETING
2022-10-25
(1) PROPOSED APPOINTMENT OF DIRECTOR; (2) PROPOSED APPOINTMENT OF SUPERVISOR; AND (3) NOTICE OF 2022 FIRST EXTRAORDINARY GENERAL MEETING
2022-10-25
PROXY FORM FOR USE AT THE 2022 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, NOVEMBER 10, 2022
2022-10-25
REPLY SLIP FOR THE 2022 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, NOVEMBER 10, 2022
2022-10-17
INSIDE INFORMATION ANNOUNCEMENT APPROVAL BY THE CSRC OF THE APPLICATION FOR "FULL CIRCULATION" OF DOMESTIC SHARES AND CERTAIN UNLISTED FOREIGN SHARES OF THE COMPANY
2022-10-09
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2022
2022-09-26
PROPOSED CHANGE OF DIRECTOR CHANGE OF COMPOSITION OF REMUNERATION COMMITTEE PROPOSED CHANGE OF SUPERVISOR AND CLOSURE OF REGISTER OF MEMBERS OF H SHARES FOR EXTRAORDINARY GENERAL MEETING
2022-09-19
2022 INTERIM REPORT
2022-09-15
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-09-14
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-09-09
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-09-05
INSIDE INFORMATION PROPOSED ISSUE OF A SHARES AND LISTING ON THE SCI-TECH BOARD OF THE SHANGHAI STOCK EXCHANGE
2022-09-05
VOLUNTARY ANNOUNCEMENT CAPITAL INJECTION INTO A MEDICAL DEVICE DEVELOPER
2022-09-05
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2022
2022-08-30
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-29
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-26
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-25
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-24
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-23
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-19
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-17
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-16
VOLUNTARY ANNOUNCEMENT ACHIEVEMENT OF PRE-SET PRIMARY CLINICAL ENDPOINT IN THE RCT OF BIOHEART BIORESORBABLE CORONARY RAPAMYCIN-ELUTING SCAFFOLD IN PATIENTS WITH CORONARY HEART DISEASE (BIOHEART-II)
2022-08-16
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-15
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-12
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-11
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE 2022 H SHARE INCENTIVE SCHEME
2022-08-08
VOLUNTARY ANNOUNCEMENT INTENTION OF THE EXECUTIVE DIRECTOR AND CONTROLLING SHAREHOLDER TO INCREASE SHAREHOLDING
2022-08-05
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
2022-08-04
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2022
2022-07-27
CHANGE IN BOARD LOT SIZE
2022-07-26
DATE OF BOARD MEETING
2022-07-07
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2022
2022-06-27
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2022-06-27
ARTICLES OF ASSOCIATION
2022-06-27
POLL RESULTS OF THE 2021 ANNUAL GENERAL MEETING HELD ON JUNE 27, 2022; RESIGNATION OF NON-EXECUTIVE DIRECTOR; AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND ADOPTION OF THE 2022 H SHARE INCENTIVE SCHEME
2022-06-21
CONNECTED TRANSACTION ACQUISITION OF MINORITY EQUITY INTERESTS AND CAPITAL INJECTION IN A MEDICAL DEVICE DEVELOPER
2022-06-02
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2022
2022-05-19
VOLUNTARY ANNOUNCEMENT BIO-HEART KICKS OFF RADIUS-HTN TRIAL AT EUROPCR
2022-05-19
REPLY SLIP FOR THE 2021 ANNUAL GENERAL MEETING
2022-05-19
PROXY FORM FOR USE AT THE 2021 ANNUAL GENERAL MEETING
2022-05-19
NOTICE OF 2021 ANNUAL GENERAL MEETING
2022-05-19
2021 WORK REPORT OF THE BOARD & THE SUPERVISORY COMMITTEE 2021 PROFIT DISTRIBUTION PLAN 2021 AUDITED FINANCIAL STATEMENTS 2021 ANNUAL REPORT REMUNERATION OF DIRECTORS AND SUPERVISORS RE-APPOINTMENT OF AUDITORS PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCI
2022-05-12
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
2022-05-11
(1) PROPOSED ADOPTION OF THE 2022 H SHARE INCENTIVE SCHEME; AND (2) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEGATEE TO HANDLE MATTERS PERTAINING TO THE 2022 H SHARE INCENTIVE SCHEME
2022-05-06
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2022
2022-04-22
2021 ANNUAL REPORT
2022-04-14
CHANGE OF DATE OF ANNUAL GENERAL MEETING AND BOOK CLOSURE PERIOD
2022-04-07
Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities
2022-03-18
ARTICLES OF ASSOCIATION
2022-03-18
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
2022-03-08
DATE OF BOARD MEETING
2022-03-04
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 28 February 2022
2022-02-16
COMPLETION OF PATIENT ENROLLMENT FOR THE CLINICAL TRIAL OF BIOHEART BIORESORBABLE SCAFFOLD (BRS) PRODUCT
2022-02-08
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2022
2022-01-26
COMPLETION OF PATIENT ENROLLMENT FOR THE CLINICAL TRIAL OF IBERIS® 2ND
2022-01-17
STABILIZING ACTIONS, END OF STABILIZATION PERIOD AND LAPSE OF OVER-ALLOTMENT OPTION
2022-01-09
VOLUNTARY ANNOUNCEMENT COMPLETION OF THE CONSTRUCTION AND THE OPERATION OF THE NEW PLANT
2022-01-06
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2021
2021-12-29
VOLUNTARY ANNOUNCEMENT BIO-HEART ANNOUNCES UPCOMING RADIUS-HTN TRIAL IN EUROPE FOR TRANSRADIAL ACCESS FOR THE TREATMENT OF UNCONTROLLED HYPERTENSION AND RESISTANT HYPERTENSION
2021-12-22
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2021-12-22
Terms of Reference of the Nomination Committee
2021-12-22
Terms of Reference of the Remuneration Committee
2021-12-22
Terms of Reference of the Audit Committee
2021-12-22
ARTICLES OF ASSOCIATION
2021-12-22
Announcement of Offer Price and Allotment Results
